MARKER THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 1.71K shares, a 28.75% decline year-over-year.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 795.00 shares, a 96.79% decline year-over-year.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 3.60K shares.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 19.50K shares.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 25.60K shares, a 6.96% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 27.52K shares.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 146.00 shares.
- MARKER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 10.42K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 1.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 25.60K shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 795.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 26.29K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 3.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 50.27K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 19.50K shares 10-Q · filed 2025-05-15 | |
| 2023-12-31 | 2.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 27.52K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 24.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2021-12-31 | -1.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 146.00 shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2016-12-31 | 10.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | 10.42K shares 10-K · filed 2017-03-14 |
| 2015-09-30 | 24.64M shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | |
| 2015-06-30 | 5.00M shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | |
| 2015-03-31 | 0.00 shares 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |